In the past decade, studies demonstrated the abilities of human and rodent c-kit+ CSCs to promote cardiac regeneration and attenuate myocardial infarction (MI) induced heart dysfunction and remodeling in various animal models [6–13]. This evidence concerns the gene KIT and myocardial infarction.